Advertisement

HindustanTimes Wed,17 Sep 2014

Glenmark pulls 2,900 bottles of ulcer drug in US

Reuters  Mumbai, April 18, 2014
First Published: 14:07 IST(18/4/2014) | Last Updated: 15:11 IST(18/4/2014)

India's Glenmark Pharmaceuticals Ltd is recalling some  2,900 bottles of its stomach ulcer drug ranitidine in the United States after a foreign tablet was found in one of the bottles. Medicines produced in India, which supplies about 40% of generic and over-the-counter drugs sold in the United States, have come under increased scrutiny by the Food and Drug Administration over the past year.

Advertisement

In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.

The lot being recalled was manufactured for Glenmark by another Indian drugmaker Shasun Pharmaceuticals Ltd, and the foreign tablet was identified to be metoprolol tartrate, a drug to treat high blood pressure, according to information posted by the FDA on Thursday.

The recall began on March 18. "Corrective actions have been implemented and the recall is limited to only one lot of material," a Glenmark representative said in a statement to Reuters. "Financially, the impact of the recall is very insignificant."


Advertisement
more from Business

Sony forecasts $2 billion loss, cites weak mobile

The Japanese electronics and entertainment conglomerate said on Wednesday it anticipates a net loss of 230 billion yen ($2.15 billion) for the fiscal year that ends March 31, 2015. Its previous forecast was for a 50 billion yen ($466 million) net loss.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved